Condition deep-dive · 6 min read

Menstrual migraine — what supplements actually have evidence

Updated 2026-05-21 · Reviewed by SupplementScore editors · No sponsorships

Menstrual migraine — attacks occurring in the perimenstrual window (days -2 to +3 relative to menses) — is driven by the rapid drop in estrogen at the end of the luteal phase. It is a recognised migraine subtype (pure menstrual migraine and menstrually-related migraine in the ICHD criteria), tends to be longer, more severe, and less responsive to acute triptan therapy than non-menstrual attacks. The evidence-based supplement layer is the same magnesium, riboflavin, and CoQ10 backbone that works for general migraine prevention — with the specific addition of cycle-timed strategies (peri-menstrual magnesium loading) that have small-trial support.

Read this first. Menstrual migraine often warrants prescription mini-prophylaxis (frovatriptan or naratriptan in the perimenstrual window) or hormonal stabilisation (continuous estrogen patch, extended-cycle pills) — these prescription options usually outperform supplements alone. If you have aura with your menstrual migraines and you smoke or are over 35, combined hormonal contraception carries elevated stroke risk and is contraindicated. Coordinate with neurology and women's health.

What actually works in trials

Tier 1 evidence · Foundational migraine prevention

Magnesium (citrate or glycinate)

400–600 mg elemental/day; cycle-timed loading from cycle day 15 through day 5

Magnesium has Tier-1 evidence in general migraine prevention; the Facchinetti 1991 trial in 20 women with menstrual migraine specifically showed reduction in attack frequency, duration, and pain intensity with 360 mg/day taken from cycle day 15 through menses. The cycle-timed loading approach (higher dose in the luteal phase and early menses) is more menstrual-migraine-specific than steady daily dosing. Magnesium citrate has good bioavailability; glycinate has GI advantages.

Tier 1 evidence · Migraine prevention backbone

Riboflavin (B2)

400 mg/day, daily (not cycle-timed)

Riboflavin 400 mg/day has Tier-1 evidence in migraine prevention (Schoenen 1998). Effect is mitochondrial — supporting cerebral energy metabolism. Takes 8–12 weeks to manifest. Daily continuous dosing across the cycle is the standard approach. Bright yellow urine is expected and benign.

Tier 2 evidence · Migraine prevention adjunct

CoQ10 (ubiquinol)

100 mg three times daily

CoQ10 300 mg/day has trial-level evidence in migraine prevention (Sandor 2005). Mitochondrial mechanism rationale similar to riboflavin; the two are often combined. Effect over 8–12 weeks. Ubiquinol form has better absorption than ubiquinone, particularly in older women.

Tier 2 evidence · Hormonal modulation

Vitamin D3 (in deficient women) and B6 (P5P)

Vit D3 2,000–4,000 IU/day; P5P 25–50 mg/day cycle-timed (luteal phase)

Vitamin D status affects migraine frequency in observational studies; trial-level repletion data are modest but the routine is well-justified. B6 has small RCT signals in PMS/PMDD and as a mild estrogen-metabolism modulator; modest case in menstrual migraine. Avoid chronic high-dose B6 (≥100 mg/day) — sensory neuropathy.

Tier 3 evidence · Acute and symptomatic adjunct

Ginger (acute, at headache onset)

250–500 mg standardised extract at attack onset, may repeat ×1

Ginger has small RCT evidence vs sumatriptan as an acute migraine treatment (Maghbooli 2014). Modest signal, useful for users who can't take triptans, well-tolerated. Ginger also has antiemetic properties relevant to migraine-associated nausea.

Tier 3 evidence · Phytoestrogen / cycle support

Chasteberry (Vitex agnus-castus)

20–40 mg/day standardised extract

Vitex has trial evidence in PMS and modest signals in menstrually-related migraine. Effect is via prolactin and indirectly via luteal-phase progesterone modulation. Effect over 3 cycles; modest. Avoid in users on dopaminergic medications.

The non-supplement layer

What to skip

What to track

A migraine diary across at least 2–3 cycles is the foundation — tracking attack day relative to menses, severity (0–10), duration, triggers, and medication use. Validated tools include MIDAS and HIT-6 for impact, and PedMIDAS for younger users. Reassess supplement regimen at 12 weeks (three menstrual cycles). For magnesium, watch ferritin and stool habit (loose stools at higher doses of citrate). For B6, watch for any new tingling or numbness — sign to reduce dose.

Practical quick-start. Daily magnesium glycinate 300–400 mg elemental; add an extra 200 mg from cycle day 15 through day 5. Riboflavin 400 mg/day continuously. CoQ10 100 mg three times daily. Test 25-OH-D and supplement to 30–50 ng/mL. Track attacks across three cycles. If supplements alone don't reduce frequency by ~50%, escalate to neurology for prescription mini-prophylaxis or hormonal stabilisation.

Educational reference, not medical advice. Menstrual migraine with aura plus age over 35 plus smoking is a stroke-risk combination that warrants careful neurology and women's health input before adding any estrogen-containing intervention.

Sources

Read more: